What are the opening hours?

Monday 8:30am - 5pm Tuesday 8:30am - 5pm Wednesday 8:30am - 5pm Thursday 8:30am - 5pm Friday 8:30am - 5pm

Institute for Health Metrics and Evaluation (IHME)

Home
United States
Seattle, WA
Institute for Health Metrics and Evaluation (IHME)

The Institute for Health Metrics and Evaluation (IHME) is an independent research center at UW Vision: All people living long lives in full health.

An independent population health research organization based at the University of Washington School of Medicine, the Institute for Health Metrics and Evaluation (IHME) works with collaborators around the world to develop timely, relevant, and scientifically valid evidence that illuminates the state of health everywhere. In making our research available and approachable, we aim to inform health pol

icy and practice in pursuit of our vision: all people living long lives in full health. Mission: IHME delivers to the world timely, relevant, and scientifically valid evidence to improve health policy and practice. Research: IHME’s research is organized around answering three critical questions that are essential to understanding the current state of population health and the strategies necessary to improve it. What are the world's major health problems? How well is society addressing these problems? How do we best dedicate resources to maximize health improvement? At the same time, we are expanding the field of health metrics by training the next generation of global health leaders in a science that is both accountable and transparent. We are also commited to data transparency and sharing and have launched the Global Health Data Exchange (GHDx) where methods and results will be freely accessible to all. Thanks to long-term funding from the Bill & Melinda Gates Foundation and support from the state of Washington, we have been able to set an ambitious agenda for the Institute.

04/29/2026

The European Association for the Study of the Liver (EASL)–The Lancet Commission 2.0 report, Implementing Sustainable Liver Health in Europe, was launched today.

The Commission brings together experts across public health, clinical medicine, economics, and policy to assess the burden of liver disease and outline evidence-based solutions.

This report was developed in collaboration with IHME and informed by Global Burden of Disease (GBD) 2023 analyses: http://ms.spr.ly/6187vyKBz

EASL - The Home of Hepatology

04/28/2026

In 2023, there were 377,000 new cases of childhood cancer and 144,000 deaths worldwide. Since 1990, new cases have been relatively stable globally, and deaths have decreased by 27%, according to recent Global Burden of Disease (GBD) 2023 research published in The Lancet.

Despite these improvements, the majority of childhood cancer burden in 2023 was in low- and middle-income countries (LMICs) — 85% of new cases, 94% of deaths, and 94% of disability-adjusted life years (or years of healthy life lost) were experienced by children living in LMICs.

“The vast majority of children with cancer live in low- and middle-income countries, where delays in diagnosis, lack of access to essential cancer treatment, and other health system limitations and barriers to care can contribute to disparities in childhood cancer burden,” said lead author Dr. Lisa Force, Assistant Professor at IHME.

Read the study from researchers at St. Jude Children's Research Hospital - Science and Medicine and IHME: http://ms.spr.ly/6184vH1A0

04/27/2026

Earlier this month, global health leaders convened for a workshop hosted by Türkiye Sağlık Enstitüleri Başkanlığı (TÜSEB) and IHME to share findings from the Global Burden of Disease (GBD) 2023 study, including GBD methodology, data sources, modeling approaches, and key health indicators.

Researchers discussed GBD 2023 estimates and analyses of Türkiye and neighboring countries, aiming to strengthen Türkiye’s health data capacity and contribute to evidence-based policymaking.

• Learn more about the recent workshop in Ankara: http://ms.spr.ly/6187v1BFv

• Explore IHME’s international partnerships: http://ms.spr.ly/6183v1BFF

04/24/2026

Global maternal deaths fell to 240,000 in 2023, but more than 100 countries did not meet the global maternal mortality target as progress slowed worldwide, according to research that analyzed Global Burden of Disease 2023 data from 2000 to 2023.

In 2023, the highest maternal mortality ratios were observed across the four regions of sub-Saharan Africa, as well as parts of the Caribbean and Oceania. Countries with particularly elevated rates included Liberia, the Central African Republic, Haiti, Eritrea, and Sierra Leone.

• Read the study: http://ms.spr.ly/6186QCUzw

04/23/2026

Today is Husky Giving Day!

As a global leader in health research, IHME’s work has played a critical role in determining the impact of health disparities, guiding evidence‑based policy decisions, and improving health worldwide.

Since its foundation in 2007, IHME has been a proud part of the University of Washington. This Husky Giving Day, we are excited to join the UW community in celebrating our shared commitment to expanding the reach, collaboration, and impact of research that informs the state of global health.

Now more than ever, supporting this work matters. Help people live longer, healthier lives by supporting IHME in honor of Husky Giving Day. Donate now: http://ms.spr.ly/6188vDrJk

04/22/2026

The global burden of metabolic liver disease remains unevenly distributed.

New findings from the Global Burden of Disease 2023 study show that metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence is highest in the Middle East and North Africa.

These patterns reflect the growing impact of metabolic risk factors, including obesity and high blood sugar, alongside disparities in health system access and prevention efforts.

Read the study: http://ms.spr.ly/6189vDpL9

04/21/2026

High-income North America had the highest burden of cancer attributable to occupational asbestos in 2023, but this region experienced the biggest declines in mortality (2%) and disability-adjusted life years (2.5%) per year from 1990 to 2023.

The second highest rates for cancer attributable to occupational asbestos were seen in Southern Latin America with 2.7 deaths per 100,000 people in 2023. Women had the highest increase in this region—per year, mortality and disability-adjusted life years (years of healthy life lost) increased by 2.3%.

This recent research, published in The Lancet Regional Health – Americas, used Global Burden of Disease 2023 data from 1990 to 2023. Learn more about the key findings: http://ms.spr.ly/6182v8tVk

04/20/2026

Childhood cancer is the eighth-leading cause of childhood death globally and causes more deaths than measles, tuberculosis, and HIV/AIDS, according to recent research published in The Lancet.

Estimates show that children in low- and middle-income countries are facing the most severe consequences from cancer: http://ms.spr.ly/6186vBa2a

(Figure 3 from the paper: The association between Socio-demographic Index and age-standardized rates of childhood cancer years of life lost in 2023, for all s*xes combined. Results are presented at the country level. Each circle represents one country, with size relative to the country’s total population aged 0–19 years.)

04/18/2026

Diet-related ischemic heart disease (IHD) is posing a substantial burden on populations around the world.

In 2023, Central Asia had the highest age-standardized death rates from diet-related IHD, while Oceania had the highest age-standardized disability-adjusted life year rates. High-income Asia Pacific region reported the lowest burden.

Learn more about diet patterns and attributable IHD in recent research published in Nature Medicine: http://ms.spr.ly/6188QhbJC

04/17/2026

More than 2.1 billion people were living with anemia worldwide in 2023, an increase from 1.9 billion under previous estimates. Nearly 200 million additional anemia cases were identified globally in 2023, with prevalence rising from 24.0% to 26.4%.

A new analysis published in The Lancet Haematology aimed to assess the impact of anemia across 204 countries from 1990 to 2023 using the World Health Organization’s 2024 elevation adjustment method (an update to its 2001 approach) and data from the Global Burden of Disease study. ↓

Researchers produced the first set of global estimates of anemia burden by location, year, age, and s*x: http://ms.spr.ly/6185QhjSt

04/16/2026

Maternal mortality has declined globally in the last two decades, but progress has slowed since 2015, according to new research.

Maternal hemorrhage and hypertensive disorders of pregnancy together account for more than 40% of maternal deaths globally, highlighting the need for improved access to antenatal care, safe delivery services, emergency obstetric care, and post-partum follow-up: http://ms.spr.ly/6180QColM

04/15/2026

Nearly 1 in 3 pregnant women in low- and middle-income countries are missing out on essential antenatal care (ANC).

In 2023, 69% of women with a live birth in low- and middle-income countries received all five basic ANC care components at least once during pregnancy, which was a major increase from 26% in 1995, but it was far from universal, according to a new study published today in The Lancet Global Health.

Read the research: http://ms.spr.ly/6183Qh6Ph

Address

3980 15th Avenue NE
Seattle, WA
98195

Opening Hours

Monday	8:30am - 5pm
Tuesday	8:30am - 5pm
Wednesday	8:30am - 5pm
Thursday	8:30am - 5pm
Friday	8:30am - 5pm

Website

http://www.healthdata.org/

Alerts

Be the first to know and let us send you an email when Institute for Health Metrics and Evaluation (IHME) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Seattle?